Playback speed
10 seconds
ESMO GI 2024 Insights: CodeBreaK 300 - Patient-Reported Tolerability of Sotorasib & Panitumumab vs. Trifluridine/Tipiracil or Regorafenib in mCRC
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Julien Taieb
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Julien Taieb
202 views
July 3, 2024
Comments 0
Login to view comments.
Click here to Login